SI-BONE, Inc. — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-06-16

Reporting Person: Freund John Gordon (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-16	Common Stock	A	8797.00	$0.00	Acquired	8797.00	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2819985.00	Indirect

Footnotes

F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a
contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.

F2: Includes 8,797 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: Shares held by Skyline Venture Partners V L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V. Dr. Freund, a member of the Issuer's board of directors, is managing director of LLC and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein.